Yimitasvir (diphosphate)
Yimitasvir (Emitasvir) diphosphate is an orally active hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor and can be used for research of chronic hepatitis C virus infection[1].
Product Specifications
CAS Number
1959593-63-5
Product Name Alternative
Emitasvir (diphosphate) ; DAG-181 (diphosphate)
UNSPSC
12352005
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/yimitasvir-diphosphate.html
Purity
99.42
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC(N[C@@H](C(C)C)C(N1[C@@H](CCC1)C2=NC3=CC=C(C4=C5C([C@H]6C[C@@H]5CC6)=C(C7=CC=C(C8=CN=C([C@H]9N(CCC9)C([C@H](C(C)C)NC(OC)=O)=O)N8)C=C7)C=C4)C=C3N2)=O)=O.O=P(O)(O)O.O=P(O)(O)O
Molecular Formula
C49H64N8O14P2
Molecular Weight
1051.03
References & Citations
[1]Huiying Rao, et al. Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without Cirrhosis. J Clin Transl Hepatol. 2020 Sep 28;8 (3) :255-261.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
